Magnetic nanoparticle contrast agents for MRI: structure-property relationships, in vivo applications, and future theranostic directions
Nanotechnology · 20.03.2026 · 37 (11) · 112001
DOI: 10.1088/1361-6528/ae4e33 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanotechnology, online erschienen am 16.03.2026. Verfasst von Bahareh Rezaei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, United States of America. Hauptthemen laut MEDLINE: Contrast Media, Magnetic Resonance Imaging, Magnetite Nanoparticles, Theranostic Nanomedicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Magnetic resonance imaging (MRI) is a non-invasive and non-ionizing imaging modality that provides high-resolution images of internal organs such as the breast, brain, and cardiovascular system, enabling three-dimensional visualization of soft tissues. While MRI offers excellent soft tissue contrast, its sensitivity can be further enhanced using contrast agents, and many clinical applications rely on exogenous agents to improve detection and diagnostic accuracy. Two primary classes are used clinically: paramagnetic substances, exemplified by gadolinium (Gd), which predominantly shorten longitudinal ( T 1 ) relaxation, and superparamagnetic iron oxide nanoparticles (SPIONs), which exert strong effects on transverse ( T 2 ) relaxation. The performance and safety of these agents are strongly influenced by their pharmacokinetics and biodistribution, including rapid recognition and clearance by the reticuloendothelial system, which can both enable liver–spleen imaging and limit target-specific contrast in other organs. In this review, we first summarize the fundamental principles of MRI contrast generation, with an emphasis on relaxation mechanisms relevant to magnetic nanoparticles (MNPs). We then discuss the use of MNPs as contrast agents in representative biomedical applications, focusing on cardiac, breast, and brain MRI and illustrating how organ-specific physiology constrains nanoparticle design and performance. Finally, we examine biocompatibility and safety considerations for both Gd-based agents and SPIONs, highlighting current regulatory concerns, open questions regarding long-term toxicity, and key challenges that must be addressed to translate next-generation nanoparticle-based MRI contrast agents into routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, United States of America.
- Department of Chemical Engineering, Texas Tech University, Lubbock, TX 79409, United States of America.
ORCID-Profile: Bahareh Rezaei, Shahriar Mostufa, Karla Mercedes Paz González, Ebrahim Azizi, Changzhi Li, Jenifer Gómez-Pastora, Rui He, Kai Wu
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- Cancer Prevention and Research Institute of Texas
- Welch Foundation
- National Heart, Lung, and Blood Institute
- Texas Tech University
Zitieren
APA
Rezaei, B., Mostufa, S., Mercedes Paz González, K., Azizi, E., Li, C., Gómez-Pastora, J., He, R., & Wu, K. (2026). Magnetic nanoparticle contrast agents for MRI: structure-property relationships, in vivo applications, and future theranostic directions. Nanotechnology, 37(11), 112001. https://doi.org/10.1088/1361-6528/ae4e33
Vancouver
Rezaei B, Mostufa S, Mercedes Paz González K, Azizi E, Li C, Gómez-Pastora J, et al. Magnetic nanoparticle contrast agents for MRI: structure-property relationships, in vivo applications, and future theranostic directions. Nanotechnology. 2026;37(11):112001. doi:10.1088/1361-6528/ae4e33
BibTeX
@article{Rezaei2026,
author = {Rezaei, Bahareh and Mostufa, Shahriar and Mercedes Paz González, Karla and Azizi, Ebrahim and Li, Changzhi and Gómez-Pastora, Jenifer and He, Rui and Wu, Kai},
title = {Magnetic nanoparticle contrast agents for MRI: structure-property relationships, in vivo applications, and future theranostic directions},
journal = {Nanotechnology},
year = {2026},
volume = {37},
number = {11},
pages = {112001},
doi = {10.1088/1361-6528/ae4e33}
}
EUVIMED